A pilot trial of innohep (tinzaparin) low molecular weight heparin for primary prophylaxis of venous thromboembolism in brain tumor patients

被引：0
|
作者：
Bohlin, C [1 ]
Penne, K [1 ]
Lyons, P [1 ]
Vredenburgh, J [1 ]
机构：
[1] Duke Univ, Hlth Syst, Durham, NC USA
来源：
ONCOLOGY NURSING FORUM | 2005年 / 32卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [31] Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxis
    Lozano, F. S.
    Sanchez-Fernandez, J.
    Gonzalez-Porras, J. R.
    Garcia-Alovio, J.
    Santos, J. A.
    Mateos, R.
    Alberca, I.
    HERNIA, 2015, 19 (06) : 901 - 908
  • [32] Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxis
    F. S. Lozano
    J. Sánchez-Fernández
    J. R. González-Porras
    J. García-Alovio
    J. A. Santos
    R. Mateos
    I. Alberca
    Hernia, 2015, 19 : 901 - 908
  • [33] Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients
    Stephanie L. Perry
    Cindy Bohlin
    David A. Reardon
    Annick Desjardins
    Allan H. Friedman
    Henry S. Friedman
    James J. Vredenburgh
    Journal of Neuro-Oncology, 2009, 95 : 129 - 134
  • [34] Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism
    Pineo, GF
    Hull, RD
    BAILLIERES CLINICAL HAEMATOLOGY, 1998, 11 (03): : 621 - 637
  • [35] Audit of low molecular weight heparin usage in prophylaxis of venous thromboembolism (VTE) in pregnancy.
    Murphy, KM
    Pasi, J
    Reid, W
    Perry, DJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 43 - 43
  • [36] Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients
    Perry, Stephanie L.
    Bohlin, Cindy
    Reardon, David A.
    Desjardins, Annick
    Friedman, Allan H.
    Friedman, Henry S.
    Vredenburgh, James J.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 95 (01) : 129 - 134
  • [37] Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: A randomized controlled trial
    Goldhaber, SZ
    Kett, DH
    Cusumano, CJ
    Kuroki, CA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 325A - 325A
  • [38] THROMBOEMBOLISM PROPHYLAXIS WITH LOW-MOLECULAR WEIGHT HEPARIN IN GYNECOLOGY
    BRIEL, RC
    HERMANN, C
    HERMANN, P
    DOLLER, P
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 72 - 73
  • [39] Low-molecular-weight heparin prescribing for venous thromboembolism in cancer patients
    Stewart, David
    Rikhye, Somi
    Odle, Brian
    Flores, Emily
    PHARMACOTHERAPY, 2013, 33 (05): : E51 - E51
  • [40] SAFETY OF DIRECT ORAL ANTICOAGULANTS AS COMPARED TO LOW MOLECULAR WEIGHT HEPARIN IN TREATING VENOUS THROMBOEMBOLISM IN PATIENTS WITH PRIMARY BRAIN TUMORS AND BRAIN METASTASES
    Ali, Assad
    Shah, Nirja
    Santiago, Raphael Bastianon
    Mandel, Mauricio
    Obrzut, Michal
    Borghei-Razavi, Hamid
    Adada, Badih
    Ranjan, Surabhi
    NEURO-ONCOLOGY, 2022, 24 : 147 - 147
12345